Welcome to our dedicated page for Bon Natural Life SEC filings (Ticker: BON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bon Natural Life Limited (NASDAQ: BON) files as a foreign private issuer with the U.S. Securities and Exchange Commission, providing investors with detailed information on its operations in the natural, health, and personal care industries. As a Cayman Islands company with principal offices in Xi’an, China, Bon uses Form 20-F for annual reporting and Form 6-K for interim and current disclosures.
On this page, you can review Bon’s Form 6-K current reports, which often include unaudited interim financial results, Sales Cooperation Agreements, and corporate updates. For example, recent 6-K filings describe how Bon’s subsidiary Xi’an App-Chem Bio (Tech) Co., Ltd. entered into non-exclusive Sales Cooperation Agreements for natural prebiotic series products, natural weight loss products, second-generation tea pigment digestive health products, and second-generation Apple Series metabolic health products, each with specified territories, terms, and guaranteed aggregate sales amounts.
Filings also provide segment-level detail on Bon’s three main product categories: fragrance compounds, health supplements (powder drinks), and bioactive food ingredients. Revenue and cost of revenue are broken out by category, with narrative explanations of changes in sales volumes, market demand, and new product lines integrating Chinese medicine into bioactive food ingredients.
Regulatory and capital markets disclosures appear in Bon’s filings as well. In 2025, multiple Form 6-Ks outline the company’s interactions with the Nasdaq Stock Market regarding minimum bid price compliance and public interest concerns, the subsequent decision by a Nasdaq Hearings Panel to allow continued listing, and the imposition of a one-year Discretionary Panel Monitor. Other filings document corporate actions such as the resignation and appointment of the Chief Financial Officer, along with related employment agreements.
Stock Titan’s interface surfaces these SEC filings with AI-powered summaries that highlight key terms in supply and cooperation agreements, segment performance drivers in interim results, and important listing or governance developments. Users can quickly scan new 6-Ks and 20-Fs, then drill into the full text on EDGAR for deeper analysis, while also monitoring how Bon’s fragrance, prebiotic, tea pigment, and bioactive ingredient businesses are described in official regulatory documents.